|
|
Volumn 28, Issue 4, 2010, Pages 154-155
|
|
Review of an Article: Aspirin for primary prevention of cardiovascular events in people with diabetes. (2010). A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
ARTICLE;
CARDIOLOGY;
CARDIOVASCULAR DISEASE;
DIABETES MELLITUS;
EVIDENCE BASED MEDICINE;
HUMAN;
MEDICAL SOCIETY;
META ANALYSIS (TOPIC);
METHODOLOGY;
PRACTICE GUIDELINE;
PRIMARY PREVENTION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RISK ASSESSMENT;
RISK REDUCTION;
UNITED STATES;
AMERICAN HEART ASSOCIATION;
ASPIRIN;
CARDIOLOGY;
CARDIOVASCULAR DISEASES;
DIABETES COMPLICATIONS;
EVIDENCE-BASED MEDICINE;
HUMANS;
META-ANALYSIS AS TOPIC;
PLATELET AGGREGATION INHIBITORS;
PRIMARY PREVENTION;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK ASSESSMENT;
RISK REDUCTION BEHAVIOR;
SOCIETIES, MEDICAL;
UNITED STATES;
|
|
EID: 78149382311
PISSN: 10620303
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jvn.2010.10.002 Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
